Literature DB >> 12582464

The clinical potentials of endogenous neurosteroids.

Doodipala S Reddy1.   

Abstract

Stress increases plasma and brain concentrations of the neurosteroids allopregnanolone and allotetrahydrodeoxycorticosterone (THDOC), which can have potent effects on GABAA receptors in the brain. Blockade of the formation of neurosteroids prevents specific biochemical and behavioral effects of stress, suggesting that those effects are dependent upon the actions of GABA(A)-receptor active neurosteroids. Recent investigations provide a better understanding of the role of endogenous neurosteroids in normal neuronal development and in the pathophysiology of brain disorders. Physiological neurosteroid fluctuations have potential implications for stress-sensitive neurological conditions such as epilepsy, infantile spasms, as well as psychiatric disorders such as schizophrenia, posttraumatic stress disorder and depression. Future studies may provide important new evidence that may not only explain acute actions of stress, but also reveal the clinical importance of neurosteroid mechanisms during chronic stress. Copyright 2002 Prous Science

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12582464     DOI: 10.1358/dot.2002.38.7.820115

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  11 in total

1.  Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice.

Authors:  Cheryl A Frye; Danielle C Llaneza
Journal:  Physiol Behav       Date:  2010-03-16

Review 2.  3alpha-hydroxy-5alpha-pregnan-20-one in the midbrain ventral tegmental area mediates social, sexual, and affective behaviors.

Authors:  C A Frye; M E Rhodes; S M Petralia; A A Walf; K Sumida; K L Edinger
Journal:  Neuroscience       Date:  2005-12-01       Impact factor: 3.590

3.  Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats.

Authors:  Khemraj Hirani; Ajay N Sharma; Nishant S Jain; Rajesh R Ugale; Chandrabhan T Chopde
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

Review 4.  Clinical Potential of Neurosteroids for CNS Disorders.

Authors:  Doodipala Samba Reddy; William A Estes
Journal:  Trends Pharmacol Sci       Date:  2016-05-05       Impact factor: 14.819

5.  PR-independent neurosteroid regulation of α2-GABA-A receptors in the hippocampus subfields.

Authors:  Doodipala Samba Reddy; Omkaram Gangisetty; Xin Wu
Journal:  Brain Res       Date:  2017-01-28       Impact factor: 3.252

Review 6.  Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action.

Authors:  Veska Uzunova; Luther Sampson; Doncho P Uzunov
Journal:  Psychopharmacology (Berl)       Date:  2005-10-26       Impact factor: 4.530

Review 7.  Neurosteroid regulation of central nervous system development.

Authors:  Synthia H Mellon
Journal:  Pharmacol Ther       Date:  2007-06-16       Impact factor: 12.310

Review 8.  Endogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C disease.

Authors:  Synthia H Mellon; Wenhui Gong; Marcus D Schonemann
Journal:  Brain Res Rev       Date:  2007-06-12

9.  Estrous cycle, pregnancy, and parity enhance performance of rats in object recognition or object placement tasks.

Authors:  Jason J Paris; Cheryl A Frye
Journal:  Reproduction       Date:  2008-04-04       Impact factor: 3.906

10.  Effects and Mechanisms of 3α,5α,-THP on Emotion, Motivation, and Reward Functions Involving Pregnane Xenobiotic Receptor.

Authors:  Cheryl A Frye; J J Paris; A A Walf; J C Rusconi
Journal:  Front Neurosci       Date:  2012-01-19       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.